Milius R P, Midgley A R, Birken S
Proc Natl Acad Sci U S A. 1983 Dec;80(24):7375-9. doi: 10.1073/pnas.80.24.7375.
125I-Labeled human choriogonadotropin (125I-hCG) bound to rat ovarian receptor was solubilized in Triton X-100. By using increasing concentrations of nine different antisera specific for the individual subunits of human choriogonadotropin (hCG), free 125I-hCG or 125I-hCG-receptor complex was precipitated by double-antibody technique. The ability of any antiserum to bind to the hormone-specific beta subunit was not affected by hCG binding to receptor, suggesting that this subunit is not directly involved with the receptor in the final state of the hormone-receptor complex. In contrast, every antiserum specific for the alpha subunit was dramatically inhibited in binding to the solubilized 125I-hCG-receptor complex. These results suggest that the alpha subunit directly interacts with the receptor, thereby masking immunoreactive sites normally available on the free hormone. Because a number of reports describe binding activity of high concentrations of immunopurified beta subunits of hCG, we propose a two-step model for the binding of hCG to receptor and postulate separate and distinct roles for the subunits. We propose that the binding of hCG to the receptor involves a specific low-affinity initial interaction of the beta subunit with the receptor that activates a second site for the high-affinity binding of alpha subunit and stabilization of the hormone-receptor complex.
与大鼠卵巢受体结合的¹²⁵I标记人绒毛膜促性腺激素(¹²⁵I-hCG)在 Triton X-100 中被溶解。通过使用针对人绒毛膜促性腺激素(hCG)各个亚基的九种不同抗血清,且浓度逐渐增加,利用双抗体技术沉淀游离的¹²⁵I-hCG 或¹²⁵I-hCG-受体复合物。任何抗血清与激素特异性β亚基结合的能力不受 hCG 与受体结合的影响,这表明该亚基在激素-受体复合物的最终状态下不直接参与与受体的相互作用。相比之下,每种针对α亚基的抗血清与溶解的¹²⁵I-hCG-受体复合物的结合都受到显著抑制。这些结果表明,α亚基直接与受体相互作用,从而掩盖了游离激素上通常可利用的免疫反应位点。由于许多报告描述了高浓度免疫纯化的 hCG β亚基的结合活性,我们提出了一个 hCG 与受体结合的两步模型,并假设各亚基具有独立且不同的作用。我们提出,hCG 与受体的结合涉及β亚基与受体的特定低亲和力初始相互作用,该相互作用激活了一个用于α亚基高亲和力结合和激素-受体复合物稳定的第二个位点。